319) Growth patterns in early life are associat |
320) adverse effects on the normal age-related growth patterns for HT, but favorable effe |
321) these effects on child dietary habits and growth patterns over time. |
322) ition, these carcinomas showed aggressive growth patterns with bronchus invasion and |
323) Growth plate fracture can lead to retarded |
324) lantation of scaffolds in proximal tibial growth plate defects in New Zealand white |
325) findings show the potential for treating growth plate injury using in vivo tissue e |
326) engineering approach for the treatment of growth plate injury via localized delivery |
327) tment for cervical cancer using the early growth response (Egr-1) promoter to contro |
328) th transcriptomic methods, only the early growth response 1 gene-coding for a transc |
329) Animal studies show a growth response in tendons in response to |
330) The growth response of Mongolian pine (Pinus s |
331) Personal growth was found to be related to the birt |
332) Tumor growth was greater in the HCT group than i |
333) The bacteria growth was not examined out in both groups |
334) r low birth weight term infants, catch-up growth was not found when using single wei |
335) amplification can be achieved inside the growth cone by multiple second messenger s |
336) that hinder axon regeneration by inducing growth cone collapse. |
337) sed to generate asymmetric changes in the growth cone turning machinery so that one |
338) Using multilevel growth curve modeling, the present study h |
339) ss reactivity conducted through piecewise growth curve modelling. |
340) Latent growth curve models showed significant inc |
341) tionally upregulates vascular endothelial growth factor-C (VEGF-C) via interaction w |
342) th recombinant human vascular endothelial growth factor-C used as a positive control |
343) an recombinant human vascular endothelial growth factor-C. |
344) rosis factor-α (TNF-α) and transforming growth factor-β1 (TGF-β) was partially r |
345) response to incubation with transforming growth factor-β1 (TGF-β1) protein, AECs |
346) eutralizing antibody against transforming growth factor-β1 (TGF-β1), SB431542, a T |
347) Latent growth models and autoregressive models we |
348) Latent growth models revealed quadratic growth in |
349) Cox regression and latent growth models were used to determine the e |
350) splay on their surface or secrete various growth or inhibitory factors that influenc |
351) ation did not reflect alterations in cell growth or programmed cell death. |
|